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Background: The United States officially entered a recession in December 2007, and it officially exited the
recession in December 2009, according to the National Bureau of Economic Research. Since the economy may
affect not only the volume of excimer laser refractive surgery, but also the clinical characteristics of patients
undergoing surgery, our goal was to compare the characteristics of patients completing excimer laser refractive
surgery and the types of procedures performed in the summer quarter in 2007 and the same quarter in 2009 at an
academic center. A secondary goal was to determine whether the volume of astigmatism- or presbyopia-correcting
intraocular lenses (IOLs) has concurrently changed because like laser refractive surgery, these “premium” IOLs
involve out-of-pocket costs for patients.
Methods: Retrospective case series. Medical records were reviewed for all patients completing surgery at the
Wilmer Laser Vision Center in the summer quarter of 2007 and the summer quarter of 2009. Outcome
measures were the proportions of treated refractive errors, the proportion of photorefractive keratectomy (PRK)
vs. laser-assisted in-situ keratomileusis (LASIK), and the mean age of patients in each quarter. Chi-square test
was used to compare the proportions of treated refractive errors and the proportions of procedures; two-tailed
t-test to compare the mean age of patients; and two-tailed z-test to compare proportions of grouped
refractive errors in 2007 vs. 2009; alpha = 0.05 for all tests. Refractive errors were grouped by the spherical
equivalent of the manifest refraction and were considered “low myopia” for 6 diopters (D) of myopia or less,
“high myopia” for more than 6 D, and “hyperopia” for any hyperopia. Billing data were reviewed to obtain the
volume of premium IOLs.
Results: Volume of laser refractive procedures decreased by at least 30%. The distribution of proportions of treated
refractive errors did not change (p = 0.10). The proportion of high myopes, however, decreased (p = 0.05). The
proportions of types of procedure changed, with an increase in the proportion of PRK between 2007 and 2009 (p
= 0.02). The mean age of patients did not change [42.4 ± 14.4 (standard deviation) years in 2007 vs. 39.6 ± 14.5
years in 2009; p = 0.4]. Astigmatism-correcting IOL and presbyopia-correcting IOL volumes increased 15-fold and
three-fold, respectively, between 2007 and 2009.
Conclusions: Volume of excimer laser refractive surgery decreased by at least 30% between 2007 and 2009. No
significant change in mean age or in the distribution of refractive error was seen, although the proportion of high
myopes decreased between summer quarters of 2007 and 2009. PRK gained as a proportion of total cases.
Premium IOL volume increased, but still comprised a very small proportion of total IOL volume.
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Background
In October 1999, VISX (Abbott Medical Optics, Santa
Ana, CA) reported 1 million procedures had been per-
formed in the United States using their excimer platform
http://www.visx.com/corporate/company_overview/
history.php; today, the company reports 6 million proce-
dures have been performed with their lasers in the US.
Intralase (AMO, Santa Ana, CA) became the first femto-
second laser approved by the Food and Drug Administra-
tion (FDA) for use in laser-assisted in-situ keratomileusis
(LASIK) in 2001. To date, 1 million procedures have
been performed using this laser. In 2003, VISX Custom-
Vue, wavefront-guided technology based on Hartmann-
Shack aberrometry, gained approval by the FDA. Despite
these milestones in technology and volume, the market
for refractive surgery has changed since these approvals.
One reason may be that the United States officially
entered a recession in December 2007, according to the
National Bureau of Economic Research (NBER) (http://
www.nber.org/cycles/dec2008.pdf). In addition, there was
much press coverage in April 2008 when the FDA con-
vened a public advisory panel of outside experts to listen
to patients unhappy with the results of their LASIK sur-
gery and to consider how to improve information for
patients and physicians about LASIK http://www.fda.gov/
MedicalDevices/ProductsandMedicalProcedures/Surger-
yandLifeSupport/LASIK/UCM061421.
It is the impression of some surgeons that the clinical
characteristics of patients seeking evaluation and under-
going refractive surgery have changed over this time. One
possible reason is that early adopters have already under-
gone surgery, and now surgeons are seeing more patients
with characteristics that might have disqualified them
from surgery in the past using older technology. It is esti-
mated that more than 60 million people are eligible for
excimer laser refractive surgery in the US alone http://
www.visx.com/corporate/company_overview/history.php,
meaning only 10% of the market has been penetrated.
Even if the market is a fraction of the estimate, given the
amount of capital investment needed for to perform
refractive laser surgery, it is of interest to surgeons (and
market-watchers) to know the type of patient undergoing
refractive surgery today. The purpose of this study was to
determine whether patient characteristics and procedure
type have changed between 2007 and 2009 at one aca-
demic center. A secondary goal was to determine whether
the volume of premium (astigmatism- or presbyopia-cor-
recting) intraocular lenses (IOLs) has changed in the same
period, since patients have to pay for these IOLs out-of-
pocket as they do for laser refractive surgery.
Methods
This chart review was conducted under a protocol
approved by the Institutional Review Board of Johns
Hopkins University and conducted in accordance with
the tenets of the Declaration of Helsinki. The Wilmer
Laser Vision Correction Center, as part of the Refractive
Surgery Service at Wilmer Eye Institute, has maintained
a prospective database of all patients who had laser
refractive surgery since January 1, 1997. All refractive
surgical candidates undergo a thorough preoperative
evaluation, including detailed medical, ocular and social
history; preoperative uncorrected distance visual acuity
(UDVA); best spectacle-corrected distance visual acuity
(BSCVA); corneal topography (Zeiss Humphrey Medi-
tec) and Orbscan (Bausch & Lomb); corneal pachymetry
by ultrasound and by Orbscan; biomicroscopic examina-
tion; pupillary examination; Schimer testing; dilated
examination; cycloplegic refraction; and cycloplegic
visual acuity. All cases of PRK and LASIK were wave-
front-guided using the VISX Star S4 CustomVue plat-
form with iris registration; the eye tracker and iris
registration were engaged in treatment of all eyes.
Clinical characteristics of patients completing excimer
laser refractive surgery [LASIK, phototherapeutic kera-
tectomy (PTK), or photorefractive keratectomy (PRK)]
in the summer quarter (July, August, September) of
2007 and the same quarter in 2009 were de-identified
and examined. Age, uncorrected visual acuity, manifest
refraction, and surgical plan (intended treatment para-
meters, whether primary or enhancement procedure,
and type of procedure–PRK, LASIK, or PTK) were
extracted. Spherical equivalent of the manifest refraction
was chosen as the means by which to categorize
patients: “low myopia” for 6 diopters of myopia or
under, “high myopia” for more than 6 diopters of myo-
pia, and “hyperopia” for any amount of hyperopia.
Billing records were used to track the volume of pre-
mium lenses implanted throughout Wilmer because
patients (not insurance companies) pay for these lenses.
A three-month time frame was chosen to attain
enough patients and to compensate for random fluctua-
tions that could occur within a shorter time frame. The
summer quarter of 2007 was chosen because it preceded
the official start of the economic recession and because
there is an impression that the economic downturn has
affected not only the volume of surgery, but also the
clinical characteristics of surgical patients.
Statistical analysis
The chi-square test was performed to compare the over
all distribution of treated refractive errors (low myopia,
high myopia, hyperopia) in the summer quarter of 2007
with the distribution in the same quarter of 2009. The
z-test was used to compare the proportion of each
group of refractive error (low myopia, high myopia,
hyperopia) in 2007 with the respective proportion in
2009 in the same quarter.
Kuo BMC Ophthalmology 2011, 11:11
http://www.biomedcentral.com/1471-2415/11/11
Page 2 of 6
The chi-square test was used to compare the distribu-
tion of procedures (PRK or LASIK) in 2007 with that in
2009. It was also used to compare the distribution of
PTK and non-PTK procedures in 2007 and 2009. The z-
test was used to compare the proportion of procedures
that were enhancements in 2007 vs. 2009. The propor-
tion was calculated as the number of enhancement pro-
cedures divided by the total number of procedures in
that quarter. The t-test was performed to compare the
mean age of patients undergoing surgery in 2007 with
that of patients having surgery in 2009. Both the z-test
and t-test were two-tailed. A p-value of < 0.05 was con-
sidered significant for all tests.
Results
Surgical volume decreased by at least 30%. The distribu-
tion of proportions of refractive errors of patients who
completed refractive surgery is displayed in Table 1.
The change in distribution of proportions between the
summer quarters of 2007 and 2009 was not statistically
significant (chi-square = 4.53, 2 degrees of freedom, p =
0.10). Examining each group of refractive error between
2007 and 2009, the proportion of high myopes changed
(z = 2, p = 0.05), but the proportions of hyperopes and
low myopes did not change (z = 1.1, p = 0.3; z = 0.9,
p = 0.4, respectively).
The distribution of proportion of procedures that were
PRK or LASIK is shown in Table 2. The distribution of
procedures changed between 2007 and 2009 (chi-square
= 5.45, 1 degree of freedom, p = 0.02), with an increase
in the proportion of PRK. A survey of the laser logs
between 2000-2009 showed that the proportion of PRK
to total volume of surgery increased from 3% in 2003 to
7% in 2006 to 17% in 2008 to 29% in 2009. PTK com-
prised 5.6% of all refractive surgery cases in the summer
quarter of 2007, and it comprised 1.3% of cases in the
summer quarter of 2009, the remainder of cases being
non-PTK procedures (PRK and LASIK, primary proce-
dures and enhancements). The distribution of proportions
of PTK vs. non-PTK cases changed between 2007 and
2009 (chi-square = 13.35, 1 degree of freedom, p < 0.001).
The percentage of enhancements (either PRK or
LASIK) increased from 4.8% in 2007 to 13.3% in 2009
(z = 2.40, p = 0.016). In 2007, enhancements were done
predominantly in patients who had undergone LASIK
previously for high myopia; the remaining 25% pre-
viously had low myopia. In 2009, 50% of enhancements
were done patients who had undergone LASIK for low
myopia, 25% on eyes with previous hyperopia, and 25%
on eyes with previous high myopia.
There was no significant difference in the mean age of
patients undergoing surgery (LASIK, PRK, or PTK). The
mean age in 2007 was 42.4 ± 14.4 (standard deviation)
years, and the mean age in 2009 was 39.6 ± 14.5 years
(t = 1.02, p = 0.4).
The number of astigmatism-correcting IOLs increased
15-fold, and the number of presbyopia-correcting IOLs
increased three-fold between 2007 and 2009. Overall
premium IOL volume increased five-fold; volume was
less than 5% of the total volume of cataract surgery at
our institution.
Discussion
With the decrease in volume of refractive surgery over
the past few years, some surgeons have had the impres-
sion that the clinical characteristics of patients seeking
surgery are changing–that patients are older (perhaps
because they have more disposable income than younger
patients) and that there are more patients with hypero-
pia or high myopia seeking surgery than before. One
rationale is that patients with poor UDVA (e.g., high
myopes) are still motivated to have refractive surgery,
whereas low myopes (whose UDVA is not as poor) pos-
sibly can forgo it. The results of this chart review done
at a single academic center over a three-month period
in 2007 and in 2009 showed that volume decreased by
at least 30% and the distribution of treated refractive
errors did not change, but the proportion of high
myopes actually decreased when refractive errors were
grouped and compared between 2007 and 2009. The
proportion of type of procedure–PRK vs. LASIK–has
Table 1 Proportion of refractive errors of patients who
underwent excimer laser refractive surgery in the
summer quarter of 2007 and the summer quarter of
2009




Excimer laser refractive surgery was comprised of photorefractive keratectomy
and laser-assisted in-situ keratomileusis. “Low myope” was defined as patients
whose spherical equivalent of the manifest refraction was 6 diopters or less of
myopia; “high myope” was defined as spherical equivalent of the manifest
refraction that was worse than 6 diopters of myopia; hyperope is defined as
any amount of hyperopia. (Percentages add up to less than 100% in 2009
because of rounding).
Table 2 Proportion of patients who underwent
photorefractive keratectomy (PRK) vs. laser-assisted in-
situ keratomileusis (LASIK) in summer quarter of 2007
and in the summer quarter of 2009
Procedure type 2007 2009
PRK 17% 29%
LASIK 83% 71%
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changed, with an increase in the proportion of cases
that were PRK between 2007 and 2009. However, there
has been no change in mean age of surgical patients.
The estimated overall prevalence rates for refractive
errors in the US population 40 years or older in the
year 2000 has been described [1]. In short, the estimated
prevalence of hyperopia was 9.9%, that of myopia 1
diopter or worse was 25.4%, and that of myopia worse
than 5 diopters was 17.4% of all persons with myopia,
for a calculated prevalence of 4.5% for myopia worse
than 5 diopters (Kempen JH, written communication,
September 24, 2010); projected prevalence rates in 2020
are similar. Given these prevalence values, it appears
that high myopes are disproportionately represented in
refractive surgery. However, the proportion of refractive
surgery patients who were high myopes decreased
between the summer quarters of 2007 and 2009 at our
center. As a group, high myopes would be expected to
remain motivated to undergo surgery compared to low
myopes even as over all interest in refractive surgery
waned. Moreover, patients with high refractive errors
(either hyperopia or myopia) may have been dissuaded
from surgery before femtosecond laser and wavefront-
guided or optimized surgery were available. Assuming a
lag between availability of new technology and the time
that suitable candidates appear for refractive surgery
evaluation, one might expect more patients with high
myopia than was observed (or at least expect the pro-
portion to stay the same between 2007 and 2009). How-
ever, this did not occur, and the decrease in proportion
of high myopia was split between an increase each in
the proportions of low myopia and hyperopia, although
each increase alone was not statistically significant. The
proportion of patients judged not to be good refractive
surgery candidates (not including patients with relative
contraindication) seems to have dropped from about
50% to 30% in the last decade (unpublished data from
our institution), so this change suggests we are offering
surgery to candidates who might not have been candi-
dates 5 to 10 years earlier. However, one reason for the
decrease in proportion of highly myopic patients might
be reaction of surgeons to the FDA advisory panel.
Amongst some surgeons, the minimum requirement for
residual stromal bed thickness has risen over the years.
One reason we chose the manifest refraction rather than
the treated refractive error as a clinical characteristic of
interest is that there is an approximate association
between UDVA and the magnitude of the spherical
equivalent of the manifest refraction. We also believe that
preoperative UDVA informs the decision of most patients
to have laser refractive surgery, although uncorrected near
visual acuity is an additional consideration when a patient
contemplates monovision correction. In our series, the fel-
low eye of patients who chose monovision still underwent
surgery to improve UDVA, meaning that UDVA (which
can reflect manifest refraction) was still important to
patients. In other words, there were no patients who were
emmetropic and underwent surgery to attain ametropia–
for example, to attain monovision.
Not only was manifest refraction a valid means to
stratify patients and also an approximate indication of
UDVA, but also in this group of patients, it was similar
to the treated refractive error and wavefront refraction.
All patients who underwent monovision correction in
this series chose “mini” monovision, wherein the goal
was 0.75 to 1 diopter of myopia, meaning the difference
between manifest and treated spherical equivalents were
not dissimilar. Wavefront and manifest refractions are
rarely exactly the same, but wavefront refractions are
always compared to manifest refractions prior to treat-
ment, and they are not allowed to differ by more than
0.50 to 0.75 diopters, depending on whether the treat-
ment is myopic or hyperopic.
The average proportion of enhancements at our center
over the past 10 years has been below 5%; the advent of
wavefront technology appears to have contributed. Sur-
prisingly, the proportion increased from 4.8% in the
summer quarter of 2007 to 13.3% in the summer quar-
ter of 2009. It is highly unlikely that surgical results
became less predictable between 2007 and 2009. More-
over, almost all enhancement cases were internal
patients, not ones referred from the community.
Although the proportion of hyperopic correction
increased between 2007 and 2009 and might have
explained the higher enhancement rate in 2009, we
found that 50% of the enhancements in 2009 were per-
formed on patients who were previously low myopes,
whereas the overwhelming majority of patients under-
going enhancement in 2007 were previously high
myopes, The increase in the proportion of cases that
were hyperopic between 2007 and 2009 may result in an
increased enhancement rate in years following 2009,
however, since a lag may occur. Therefore instead of the
reason being a higher percentage of hyperopic first-time
treatments, this increase in proportion of enhancements
is likely a result of the change in over all volume of
refractive surgery (the denominator). Surgical volume
has decreased worldwide, most likely because of the glo-
bal financial crisis http://www.crstodayeurope.com/
Issues/0309/0309_04.pdf, http://www.aao.org/isrs/
resources/trendssurvey.cfm; volume in Europe and the
United States has decreased by 20-30% with our center
being no exception. Prices of procedures at our center
have remained stable. Academic centers have tradition-
ally charged higher prices, most likely due to higher
overhead. The average price of our competitors, how-
ever, has grown closer to our prices as centers offering
far below-market prices have gone out of business.
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Between 2007 and 2009, our advertising budget shrank
as a result of decreased revenue from surgery; the smal-
ler budget may or may not have contributed to further
erosion of volume. Moreover, at our center, the surgical
fee includes follow-ups and enhancements done within
two years of surgery. One possibility is that with the
decrease in surgical volume (the denominator), fewer
new patients underwent surgery, replaced by a larger
percentage of patients who had had previous refractive
surgery at our center, who qualified for an enhance-
ment, and for whom cost was no barrier.
We noted a higher proportion of PRK in the summer
quarter of 2009 than in 2007. The rise in proportion of
PRK cases has been steady since 2000 to 2009, from 3%
to 25%. In general, many surgeons are performing more
PRK than they did in the past [2]; reasons include con-
cerns about residual stromal bed thickness in LASIK vs.
PRK, decreased risk of PRK-associated haze with
advances in laser technology, use of mitomycin-C,
LASIK flap complications, and findings that PRK
induces lower amounts of higher order aberrations than
does LASIK, both in conventional [3-5] and wavefront-
guided settings [2]. A large review found conventional
PRK and LASIK to be comparable in all aspects of visual
acuity, although the investigators did not evaluate higher
order aberrations [6]. In this series, PRK was performed
on high myopes with thin corneas and for primary pro-
cedures and enhancements to correct low refractive
error. Enhancements were split between PRK and
LASIK, such that the higher proportion of enhance-
ments in 2009 cannot account for the increase in PRK.
The proportion of PTK cases decreased drastically.
Between 2007 and 2009 at our center, PTK became a
self-pay procedure. This arrangement likely had an
impact on the number of PTK cases done, although
PTK, unlike LASIK and PRK, is used to treat conditions
that are not correctable with spectacles or contact
lenses. One may therefore argue that PTK should not be
compared with purely refractive procedures like LASIK
and PRK. However, we chose to examine the distribu-
tion of PTK and non-PTK procedures because all are
self-pay procedures at our center. Moreover, because
PTK is a therapeutic procedure and patients are drawn
from the larger community, one would expect the
volume of PTK to remain stable. One might even expect
the proportion of PTK over the volume of all excimer
laser procedures to increase as volume of procedures
(denominator) decreased, but instead the proportion of
PTK decreased between 2007 and 2009. Very few refrac-
tive surgeons in our metropolitan area offer PTK any-
more, so it is not clear where patients are seeking
treatment if not at our tertiary center and if at all.
Although we expected to see the mean age of patients
increase from 2007 to 2009 because older patients might
have higher disposable income compared to younger
patients, we found there was no difference. More patients
in 2009 underwent laser refractive surgery to correct
ametropia following cataract extraction with implanta-
tion of a presbyopia-correcting lens than did in 2007. A
history of cataract extraction would imply an older set of
patients, but the increase in the number of post-cataract
patients between 2007 and 2009 was outweighed by the
relative youth of the other patients undergoing refractive
surgery.
Whereas laser refractive surgery is a completely elec-
tive procedure, the overwhelming majority of patients
undergoing premium (presbyopia- or astigmatism-cor-
recting) intraocular lens (IOL) implantation undergo
cataract extraction at the same time; in other words,
they are not clear lens exchanges. At Wilmer, when
combined with cataract extraction, the out-of-pocket
cost (i.e., borne by the patient, not by insurance) of a
presbyopia-correcting IOL is the same as LASIK or
PRK; the toric IOL is 50% less. Presumably, because
these are not clear lens exchanges, these patients might
be less price-sensitive. The volume of these IOLs at Wil-
mer increased manifold between 2007 and 2009. Overall,
however, premium IOLs comprised a very small propor-
tion of total cataract volume at Wilmer between 2007
and 2009. Moreover, the volume of these IOLs was at
least a magnitude smaller than the volume of laser
refractive procedures. Therefore, volume and revenue
changes in laser refractive surgery at our center are not
being recouped in premium IOLs.
Conclusions
Several limitations are inherent in this study. A three-
month time frame was chosen to attain enough patients
to detect trends without obscuration by random fluctua-
tions. One reason the year 2007 was chosen was that it
preceded the official start of the economic recession. In
addition, many surgeons sense that refractive surgery
volume has been decreasing since 2007 (or earlier) and
that it continues to decrease. This sentiment persists
despite the official end of the recession in December
2009, published by the NBER. Therefore, one critique
may be that the time points should be further apart, e.
g., 2005 and 2010 or 2009 and 2014, especially since
patient/consumer interest may lag changes in the overall
economy. Moreover, this three-month survey may be
only a snapshot of patient characteristics and procedure
types that may or may not be validated by larger studies.
In addition, the summer quarter may be different from
other quarters for reasons we do not know. Last,
patients at an academic center may be quite different
from those in the community. Nonetheless this three-
month survey done in 2007 and again in 2009 shows
that there is a change in the proportion of high myopes,
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in the types of procedures (PRK vs. LASIK; PTK vs. PRK
and LASIK), and in the proportion of enhancement pro-
cedures being performed at our center. Premium IOL
implantation increased in the same period, but such
IOLs still constitute a very small fraction of the total
IOLs implanted in our department. A larger study with
a longer time frame may be required to show whether
there truly has been no change in the distribution of
treated refractive errors or in the mean age of patients.
Concomitant with such a study might be comparisons
with and/or cumulative analysis of data from other aca-
demic centers and community practices.
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